A Phase II study to evaluate the safety and histological response to Rituximab in adults with Sjogren's Syndrome
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 08 Dec 2011 New trial record